Share Price and Basic Stock Data
Last Updated: December 6, 2025, 10:21 pm
| PEG Ratio | -1.49 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Uniphos Enterprises Ltd, with a market capitalization of ₹999 Cr and a current share price of ₹144, has seen varied revenue trends over the years. The company reported sales of merely ₹1 Cr in FY 2023, a stark contrast to the ₹51 Cr projected for FY 2024, highlighting a significant turnaround. However, this rebound in revenue is not without its caveats. The company recorded a staggering ₹50.65 Cr in sales for Q4 FY 2024, showcasing a potential recovery phase, but the subsequent quarter saw a decline to ₹3.03 Cr. The erratic sales figures, particularly zeroing out in multiple quarters, raise questions about the sustainability of this growth. The company’s revenue per share stood at ₹16.03 for FY 2025, a figure that, while improving, suggests that Uniphos is still in a phase of rebuilding its operational foundation. The volatility in revenue, combined with the historical context of zero sales in preceding years, indicates a company trying to find its footing in a challenging market environment.
Profitability and Efficiency Metrics
Profitability metrics for Uniphos paint a concerning picture. The company reported a negative operating profit margin of -14.33% for FY 2025, which indicates that it is currently struggling to convert its sales into profits. Over the past few years, operating profit has consistently been in the negative territory, illustrating ongoing challenges in managing costs effectively. The return on equity (ROE) is a mere 0.01%, while the return on capital employed (ROCE) stands at 0.06%, both of which are significantly below industry benchmarks. This suggests that Uniphos is not generating sufficient returns for shareholders relative to their investments. Furthermore, the interest coverage ratio (ICR) of 1.75x indicates that while the company can cover its interest obligations, it is doing so with a narrow margin. These metrics highlight the need for a strategic overhaul in operational efficiency and cost management to improve profitability and ultimately shareholder value.
Balance Sheet Strength and Financial Ratios
Uniphos Enterprises boasts a relatively strong balance sheet, with total reserves standing at ₹2,831 Cr and borrowings at a negligible ₹1 Cr. This low debt level indicates that the company is not under financial strain from debt repayments, which is a positive sign. However, the price-to-book value (P/BV) ratio of 0.41x suggests that the stock is undervalued compared to its net asset value. On the flip side, the current ratio of 8.83 indicates an exceptionally strong liquidity position, suggesting that the company has ample short-term assets to cover its liabilities. Yet, the efficiency metrics, including a cash conversion cycle hovering around zero days, imply that while liquidity is strong, the company may struggle with operational efficiency. The financial ratios indicate a company that, while solvent and liquid, has yet to translate these strengths into effective operational performance.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Uniphos reveals a stable commitment from its promoters, who hold 73.79% of the shares, thus indicating a strong alignment with long-term business interests. Foreign institutional investors (FIIs) have a notable stake of 15.71%, which reflects some level of confidence in the company’s future. However, the public float of just 10.50% suggests limited retail investor participation, which may affect liquidity and market interest. The number of shareholders has fluctuated but shows a slight increase, indicating some growing interest, although it remains in the lower range. This concentrated shareholding can be a double-edged sword; while it provides stability, it may also limit broader market engagement. Therefore, while the promoter commitment is a strength, the lack of widespread investor confidence could pose challenges in attracting new capital or driving share price appreciation.
Outlook, Risks, and Final Insight
Looking ahead, Uniphos Enterprises faces a mixed outlook. On one hand, the potential for revenue recovery is evident, as indicated by the recent sales uptick in Q4 FY 2024. However, the volatility in revenue and persistent profitability challenges create significant risks. The company must navigate its operational inefficiencies while capitalizing on any newfound revenue streams. Moreover, the high dependency on promoter holdings may deter new investments, particularly from retail investors. Investors should consider the stock’s current valuation against its operational struggles; while the low P/BV might suggest an attractive entry point, the underlying business performance raises red flags. In essence, Uniphos represents a speculative bet; it holds promise if management can turn around operational performance, yet it also carries risks that could hinder any potential upside. As always, investors should weigh these factors carefully before making decisions regarding their portfolios.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Uniphos Enterprises Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 105 Cr. | 27.4 | 808/26.3 | 1.03 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 1,721 Cr. | 170 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 48.4 Cr. | 3.79 | 8.65/3.55 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,875.86 Cr | 225.03 | 430.34 | 219.29 | 0.25% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 1.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 50.65 | 3.03 | 30.48 | 5.10 | 72.90 | 5.86 |
| Expenses | 0.65 | 2.25 | 0.71 | 0.73 | 0.79 | 0.75 | 0.69 | 51.51 | 3.78 | 30.96 | 6.10 | 74.50 | 6.70 |
| Operating Profit | -0.65 | -0.78 | -0.71 | -0.73 | -0.79 | -0.75 | -0.69 | -0.86 | -0.75 | -0.48 | -1.00 | -1.60 | -0.84 |
| OPM % | -53.06% | -1.70% | -24.75% | -1.57% | -19.61% | -2.19% | -14.33% | ||||||
| Other Income | 0.79 | 40.28 | 0.87 | 1.15 | 0.91 | 40.44 | 0.87 | 0.65 | 0.79 | 4.67 | 0.45 | 0.21 | 0.27 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 1.17 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.15 | 0.22 | 0.22 | 0.21 | 0.21 | 0.21 | 0.21 | 0.19 | 0.19 | 0.19 | 0.19 | 0.17 |
| Profit before tax | 0.13 | 39.35 | -0.06 | 0.20 | -0.09 | 39.48 | -0.03 | -0.42 | -0.15 | 3.86 | -1.91 | -1.58 | -0.74 |
| Tax % | 0.00% | 0.13% | 1,016.67% | -135.00% | 0.00% | 0.30% | 0.00% | 50.00% | 0.00% | 0.00% | -2.62% | 0.00% | 0.00% |
| Net Profit | 0.13 | 39.30 | -0.67 | 0.47 | -0.08 | 39.36 | -0.03 | -0.63 | -0.15 | 3.86 | -1.86 | -1.58 | -0.74 |
| EPS in Rs | 0.02 | 5.65 | -0.10 | 0.07 | -0.01 | 5.66 | -0.00 | -0.09 | -0.02 | 0.56 | -0.27 | -0.23 | -0.11 |
Last Updated: August 20, 2025, 1:50 am
Below is a detailed analysis of the quarterly data for Uniphos Enterprises Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 5.86 Cr.. The value appears to be declining and may need further review. It has decreased from 72.90 Cr. (Mar 2025) to 5.86 Cr., marking a decrease of 67.04 Cr..
- For Expenses, as of Jun 2025, the value is 6.70 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 74.50 Cr. (Mar 2025) to 6.70 Cr., marking a decrease of 67.80 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.84 Cr.. The value appears strong and on an upward trend. It has increased from -1.60 Cr. (Mar 2025) to -0.84 Cr., marking an increase of 0.76 Cr..
- For OPM %, as of Jun 2025, the value is -14.33%. The value appears to be declining and may need further review. It has decreased from -2.19% (Mar 2025) to -14.33%, marking a decrease of 12.14%.
- For Other Income, as of Jun 2025, the value is 0.27 Cr.. The value appears strong and on an upward trend. It has increased from 0.21 Cr. (Mar 2025) to 0.27 Cr., marking an increase of 0.06 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.17 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.19 Cr. (Mar 2025) to 0.17 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.74 Cr.. The value appears strong and on an upward trend. It has increased from -1.58 Cr. (Mar 2025) to -0.74 Cr., marking an increase of 0.84 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.74 Cr.. The value appears strong and on an upward trend. It has increased from -1.58 Cr. (Mar 2025) to -0.74 Cr., marking an increase of 0.84 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.11. The value appears strong and on an upward trend. It has increased from -0.23 (Mar 2025) to -0.11, marking an increase of 0.12.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:13 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 51 | 112 | 114 |
| Expenses | 10 | 3 | 1 | 2 | 2 | 3 | 2 | 4 | 4 | 4 | 54 | 115 | 118 |
| Operating Profit | -1 | -1 | -1 | -2 | -2 | -3 | -2 | -3 | -3 | -3 | -3 | -4 | -4 |
| OPM % | -6% | -47% | -987% | -370% | -257% | -195% | -6% | -3% | -3% | ||||
| Other Income | 7 | 11 | 14 | 13 | 20 | 24 | 23 | 26 | 57 | 43 | 43 | 6 | 6 |
| Interest | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | -2 | 9 | 12 | 11 | 18 | 21 | 20 | 23 | 54 | 40 | 39 | 0 | -0 |
| Tax % | 0% | 0% | 0% | 0% | 2% | 2% | 2% | -4% | -1% | 1% | 1% | -22% | |
| Net Profit | -2 | 9 | 12 | 11 | 18 | 21 | 20 | 24 | 55 | 39 | 39 | 0 | -0 |
| EPS in Rs | -0.23 | 1.23 | 1.70 | 1.62 | 2.54 | 2.99 | 2.89 | 3.52 | 7.85 | 5.64 | 5.55 | 0.04 | -0.05 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 97% | 72% | 115% | 103% | 1,242% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 550.00% | 33.33% | -8.33% | 63.64% | 16.67% | -4.76% | 20.00% | 129.17% | -29.09% | 0.00% | -100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -516.67% | -41.67% | 71.97% | -46.97% | -21.43% | 24.76% | 109.17% | -158.26% | 29.09% | -100.00% |
Uniphos Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 50% |
| 5 Years: | 244% |
| 3 Years: | 350% |
| TTM: | 113% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -29% |
| 5 Years: | -58% |
| 3 Years: | -83% |
| TTM: | -101% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 18% |
| 3 Years: | 5% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 249 | 258 | 270 | 2,053 | 2,076 | 2,684 | 1,504 | 2,701 | 3,167 | 2,984 | 2,062 | 2,728 | 2,831 |
| Borrowings | 10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Liabilities | 7 | 0 | 0 | 0 | 0 | 0 | 1 | 57 | 121 | 98 | 2 | 100 | 117 |
| Total Liabilities | 281 | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,078 | 2,842 | 2,962 |
| Fixed Assets | 174 | 174 | 174 | 175 | 175 | 175 | 175 | 176 | 176 | 184 | 183 | 182 | 182 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 84 | 84 | 84 | 1,856 | 1,871 | 2,483 | 1,261 | 2,550 | 3,080 | 2,856 | 1,802 | 2,616 | 2,735 |
| Other Assets | 23 | 24 | 26 | 36 | 44 | 40 | 83 | 46 | 46 | 55 | 92 | 44 | 46 |
| Total Assets | 281 | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,078 | 2,842 | 2,962 |
Below is a detailed analysis of the balance sheet data for Uniphos Enterprises Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,831.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,728.00 Cr. (Mar 2025) to 2,831.00 Cr., marking an increase of 103.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 117.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 100.00 Cr. (Mar 2025) to 117.00 Cr., marking an increase of 17.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,962.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,842.00 Cr. (Mar 2025) to 2,962.00 Cr., marking an increase of 120.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 182.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 182.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 2,735.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,616.00 Cr. (Mar 2025) to 2,735.00 Cr., marking an increase of 119.00 Cr..
- For Other Assets, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 2.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,962.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,842.00 Cr. (Mar 2025) to 2,962.00 Cr., marking an increase of 120.00 Cr..
Notably, the Reserves (2,831.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -11.00 | -11.00 | -1.00 | -2.00 | -2.00 | -3.00 | -2.00 | -3.00 | -3.00 | -3.00 | -3.00 | -4.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | -0 | -0 | -0 | -0 | -0 | -0 | 3 | -0 | ||||
| Inventory Days | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | -0 | -0 | -0 | -0 | -0 | -0 | 3 | -0 | ||||
| Working Capital Days | -692 | -1,982 | 24,772 | 6,680 | 4,434 | 17 | -11 | -6 | ||||
| ROCE % | 2% | 3% | 4% | 1% | 1% | 1% | 1% | 1% | 2% | 1% | 1% | 0% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| Diluted EPS (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| Cash EPS (Rs.) | 0.14 | 5.67 | 5.73 | 7.86 | 3.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 373.37 | 277.58 | 410.17 | 436.48 | 369.50 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 394.22 | 298.43 | 431.02 | 457.33 | 390.35 |
| Dividend / Share (Rs.) | 0.50 | 5.70 | 6.50 | 5.65 | 3.40 |
| Revenue From Operations / Share (Rs.) | 16.03 | 7.28 | 0.21 | 0.17 | 0.11 |
| PBDIT / Share (Rs.) | 0.33 | 5.72 | 5.78 | 7.76 | 3.37 |
| PBIT / Share (Rs.) | 0.22 | 5.60 | 5.70 | 7.76 | 3.36 |
| PBT / Share (Rs.) | 0.03 | 5.60 | 5.70 | 7.76 | 3.36 |
| Net Profit / Share (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| PBDIT Margin (%) | 2.06 | 78.53 | 2732.78 | 4417.35 | 2813.99 |
| PBIT Margin (%) | 1.38 | 76.89 | 2691.84 | 4414.67 | 2809.84 |
| PBT Margin (%) | 0.20 | 76.89 | 2691.84 | 4414.67 | 2809.84 |
| Net Profit Margin (%) | 0.24 | 76.24 | 2664.95 | 4469.11 | 2936.36 |
| Return on Networth / Equity (%) | 0.01 | 2.00 | 1.37 | 1.79 | 0.95 |
| Return on Capital Employeed (%) | 0.05 | 1.87 | 1.28 | 1.63 | 0.84 |
| Return On Assets (%) | 0.00 | 1.85 | 1.26 | 1.65 | 0.88 |
| Asset Turnover Ratio (%) | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 |
| Current Ratio (X) | 8.83 | 23.44 | 50.39 | 100.10 | 229.58 |
| Quick Ratio (X) | 8.83 | 23.44 | 50.39 | 100.10 | 229.58 |
| Dividend Payout Ratio (NP) (%) | 14244.01 | 117.06 | 100.17 | 43.30 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3837.47 | 114.59 | 98.65 | 43.27 | 0.00 |
| Earning Retention Ratio (%) | -14144.01 | -17.06 | -0.17 | 56.70 | 0.00 |
| Cash Earning Retention Ratio (%) | -3737.47 | -14.59 | 1.35 | 56.73 | 0.00 |
| Interest Coverage Ratio (X) | 1.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 1.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 1068.15 | 884.06 | 1038.32 | 913.70 | 586.13 |
| EV / Net Operating Revenue (X) | 9.58 | 17.46 | 705.43 | 747.83 | 703.89 |
| EV / EBITDA (X) | 464.68 | 22.23 | 25.81 | 16.93 | 25.01 |
| MarketCap / Net Operating Revenue (X) | 9.72 | 18.39 | 727.16 | 753.35 | 709.07 |
| Retention Ratios (%) | -14144.01 | -17.06 | -0.17 | 56.69 | 0.00 |
| Price / BV (X) | 0.41 | 0.48 | 0.37 | 0.30 | 0.22 |
| Price / Net Operating Revenue (X) | 9.72 | 18.39 | 727.32 | 753.70 | 709.87 |
| EarningsYield | 0.00 | 0.04 | 0.03 | 0.05 | 0.04 |
After reviewing the key financial ratios for Uniphos Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 3. It has decreased from 5.67 (Mar 24) to 0.14, marking a decrease of 5.53.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 373.37. It has increased from 277.58 (Mar 24) to 373.37, marking an increase of 95.79.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 394.22. It has increased from 298.43 (Mar 24) to 394.22, marking an increase of 95.79.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 5.70 (Mar 24) to 0.50, marking a decrease of 5.20.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 16.03. It has increased from 7.28 (Mar 24) to 16.03, marking an increase of 8.75.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 2. It has decreased from 5.72 (Mar 24) to 0.33, marking a decrease of 5.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 0.22, marking a decrease of 5.38.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 0.03, marking a decrease of 5.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 2. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For PBDIT Margin (%), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 10. It has decreased from 78.53 (Mar 24) to 2.06, marking a decrease of 76.47.
- For PBIT Margin (%), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 10. It has decreased from 76.89 (Mar 24) to 1.38, marking a decrease of 75.51.
- For PBT Margin (%), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 10. It has decreased from 76.89 (Mar 24) to 0.20, marking a decrease of 76.69.
- For Net Profit Margin (%), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 5. It has decreased from 76.24 (Mar 24) to 0.24, marking a decrease of 76.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 15. It has decreased from 2.00 (Mar 24) to 0.01, marking a decrease of 1.99.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 10. It has decreased from 1.87 (Mar 24) to 0.05, marking a decrease of 1.82.
- For Return On Assets (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 1.85 (Mar 24) to 0.00, marking a decrease of 1.85.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.04. It has increased from 0.01 (Mar 24) to 0.04, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 8.83. This value exceeds the healthy maximum of 3. It has decreased from 23.44 (Mar 24) to 8.83, marking a decrease of 14.61.
- For Quick Ratio (X), as of Mar 25, the value is 8.83. This value exceeds the healthy maximum of 2. It has decreased from 23.44 (Mar 24) to 8.83, marking a decrease of 14.61.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14,244.01. This value exceeds the healthy maximum of 50. It has increased from 117.06 (Mar 24) to 14,244.01, marking an increase of 14,126.95.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3,837.47. This value exceeds the healthy maximum of 50. It has increased from 114.59 (Mar 24) to 3,837.47, marking an increase of 3,722.88.
- For Earning Retention Ratio (%), as of Mar 25, the value is -14,144.01. This value is below the healthy minimum of 40. It has decreased from -17.06 (Mar 24) to -14,144.01, marking a decrease of 14,126.95.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -3,737.47. This value is below the healthy minimum of 40. It has decreased from -14.59 (Mar 24) to -3,737.47, marking a decrease of 3,722.88.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 24) to 1.75, marking an increase of 1.75.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 24) to 1.21, marking an increase of 1.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,068.15. It has increased from 884.06 (Mar 24) to 1,068.15, marking an increase of 184.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.58. This value exceeds the healthy maximum of 3. It has decreased from 17.46 (Mar 24) to 9.58, marking a decrease of 7.88.
- For EV / EBITDA (X), as of Mar 25, the value is 464.68. This value exceeds the healthy maximum of 15. It has increased from 22.23 (Mar 24) to 464.68, marking an increase of 442.45.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.72. This value exceeds the healthy maximum of 3. It has decreased from 18.39 (Mar 24) to 9.72, marking a decrease of 8.67.
- For Retention Ratios (%), as of Mar 25, the value is -14,144.01. This value is below the healthy minimum of 30. It has decreased from -17.06 (Mar 24) to -14,144.01, marking a decrease of 14,126.95.
- For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.48 (Mar 24) to 0.41, marking a decrease of 0.07.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.72. This value exceeds the healthy maximum of 3. It has decreased from 18.39 (Mar 24) to 9.72, marking a decrease of 8.67.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.00, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uniphos Enterprises Ltd:
- Net Profit Margin: 0.24%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.05% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.01% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.21
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 8.83
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 52.6 (Industry average Stock P/E: 430.34)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.24%
About the Company
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 11, G.I.D.C., Vapi, Valsad District Gujarat 396195 | uel.investors@upl-ltd.com http://www.uelonline.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arun Chandrasen Ashar | Chairman & Non-Exe.Director |
| Mrs. Sandra Rajnikant Shroff | Non Executive Vice Chairman |
| Mr. Rajnikant Devidas Shroff | Managing Director |
| Mr. Jaidev Rajnikant Shroff | Non Executive Director |
| Mr. Pradeep Vedprakash Goyal | Independent Director |
| Mrs. Swati Sandesh Mayekar | Independent Director |
Uniphos Enterprises Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹150.80 |
| Previous Day | ₹154.80 |
FAQ
What is the intrinsic value of Uniphos Enterprises Ltd?
Uniphos Enterprises Ltd's intrinsic value (as of 06 December 2025) is 1.73 which is 98.80% lower the current market price of 144.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 999 Cr. market cap, FY2025-2026 high/low of 193/123, reserves of ₹2,831 Cr, and liabilities of 2,962 Cr.
What is the Market Cap of Uniphos Enterprises Ltd?
The Market Cap of Uniphos Enterprises Ltd is 999 Cr..
What is the current Stock Price of Uniphos Enterprises Ltd as on 06 December 2025?
The current stock price of Uniphos Enterprises Ltd as on 06 December 2025 is 144.
What is the High / Low of Uniphos Enterprises Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uniphos Enterprises Ltd stocks is 193/123.
What is the Stock P/E of Uniphos Enterprises Ltd?
The Stock P/E of Uniphos Enterprises Ltd is 52.6.
What is the Book Value of Uniphos Enterprises Ltd?
The Book Value of Uniphos Enterprises Ltd is 409.
What is the Dividend Yield of Uniphos Enterprises Ltd?
The Dividend Yield of Uniphos Enterprises Ltd is 0.35 %.
What is the ROCE of Uniphos Enterprises Ltd?
The ROCE of Uniphos Enterprises Ltd is 0.06 %.
What is the ROE of Uniphos Enterprises Ltd?
The ROE of Uniphos Enterprises Ltd is 0.01 %.
What is the Face Value of Uniphos Enterprises Ltd?
The Face Value of Uniphos Enterprises Ltd is 2.00.